Table 2.
First site of progression by treatment type
Factor | Treatment, n (%)
|
p value | ||
---|---|---|---|---|
Erlotinib (n=52) |
Whole-brain radiation therapy (n=25) |
Stereotactic Radiosurgery (n=14) |
||
First site of progression | 0.004 | |||
Outside of the brain | 21 (41) | 19 (76) | 4 (29) | |
Brain or both at same time | 30 (59) | 6(24) | 10 (71) |